Skip to main content
. 2023 Dec 14;28(24):8095. doi: 10.3390/molecules28248095

Figure 8.

Figure 8

Figure 8

Preliminary cell viability data for (anthracene-9-yl)methylamines, (anthracene-9-yl)methylimines and (anthracene-9-yl)caboxamines in MUTU-I (Panel A) and DG-75 (Panel B) Burkitt’s lymphoma cell lines. The cell proliferation of MUTU-I and DG-75 cells was determined with an alamarBlue assay (seeding density 1–5 × 104 cells/mL per well for 96-well plates). Compound concentrations of either 1 μM or 10 μM for 24 h (MUTU-I) or 48 h (DG-75) were used to treat the cells (in triplicate) with control wells containing vehicle ethanol (1% v/v). The mean value for three independent experiments is shown.